The results also showed that BRD4 had significant difference (logrank p < 0.05) in the prognosis of GBM, while BRD1, BRD2, BRD3 and BRDT had no significant difference (Supplementary Figure S2). The gene discussed is BRD3; the disease is glioblastoma.